Literature DB >> 2992754

Heterogeneous estrogen receptor levels detected via multiple microsamples from individual breast cancers.

J P van Netten, F T Algard, P Coy, S J Carlyle, M L Brigden, K R Thornton, S Peter, T Fraser, M P To.   

Abstract

Twenty-six surgical breast cancer specimens were subjected to multiple estrogen receptor (ER) assays with a microsample technique. In most tumors there were large variations in ER levels in samples taken from different regions of the same tumor. After correction of individual samples for differences in carcinoma content, such variations were not abolished. Nine of the 26 breast cancers, although positive overall, were devoid of ER in some regions. For ER-positive tumors the average coefficient of variation (CV) for intratumor ER levels was 86%, with a range from 25% to 200%. This is well above the CV obtained with repeat samples of homogeneous tissue (14%). These results suggest that many ER-positive cancers may be composed of cells with a variety of ER levels. An assessment of individual intratumor ER variability may have biologic and clinical significance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992754     DOI: 10.1002/1097-0142(19851015)56:8<2019::aid-cncr2820560822>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Cellularity and oestrogen receptor content in breast cancer microsamples.

Authors:  J P van Netten; P Coy; C Fletcher
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

2.  Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.

Authors:  W Remmele; U Hildebrand; H A Hienz; P J Klein; M Vierbuchen; L J Behnken; B Heicke; E Scheidt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.

Authors:  S von Kleist; J Berling; J Koltzenburg; H Gropp
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis.

Authors:  H M Scheres; A F De Goeij; M J Rousch; G G Hondius; D D Willebrand; A H Gijzen; F T Bosman
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

5.  Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2.

Authors:  S P Robinson; D Goldstein; P L Witt; E C Borden; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

Review 6.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  [Biological significance of estrogen receptor status in axillary lymph node metastases of invasive ductal breast cancers].

Authors:  H A Horst; H P Horny; H J Gent; C Sellschopp; J Hedderich
Journal:  Klin Wochenschr       Date:  1988-12-01

8.  Changes in intrinsic subtype of breast cancer during tumor progression in the same patient.

Authors:  Chungyeul Kim; Jungjoo Lee; Wonyoung Lee; Aeree Kim
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Measurement of oestrogen receptor mRNA levels in human breast tumours.

Authors:  J A Henry; S Nicholson; J R Farndon; B R Westley; F E May
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

10.  Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?

Authors:  R A Hawkins; A L Tesdale; E D Anderson; P A Levack; U Chetty; A P Forrest
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.